Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00401284 · ClinicalTrials.gov registry record · Phase 2
Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness
A Phase 2 study of Sleep Initiation and Maintenance Disorders, sponsored by Evotec Neurosciences.
- Completed
- Registry status
- Phase 2
- Development phase
- 135
- Enrollment target
- 20
- Study locations
NCT00401284: Completed Phase 2 study of Sleep Initiation and Maintenance Disorders, sponsored by Evotec Neurosciences.
NCT00401284 is a Phase 2 study of Sleep Initiation and Maintenance Disorders that has completed, run by Evotec Neurosciences. The registered enrollment target is 135 participants, below the 283-participant average among 19 other Sleep Initiation and Maintenance Disorders trials with a reported enrollment target (52% lower). The trial reports 20 study locations across 13 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00401284, a Phase 2 study of Sleep Initiation and Maintenance Disorders, has completed, sponsored by Evotec Neurosciences.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 135 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating elderly patients diagnosed with primary insomnia who also have moderate daytime sleepiness.
Conditions Studied
Interventions
- DRUG EVT 201
Study Locations (20)
Florida
- Miami Research Associates - Miami
- OmniTrials, 11181 Health Park Blvd, Suite 3040 - Naples
- Broward Research Group - Pembroke Pines
- Clinical Research Group of St Petersburg Inc., 2525 Pasadena Ave So, Suite S - St. Petersburg
Arizona
- PsyPharma Clinical Research Inc. - Phoenix
- PsyPharma Clinical Research, Inc. - Tucson
California
- Pacific Sleep Medicine Services Inc - Los Angeles
- Pacific Sleep Medicine Services - San Diego
Georgia
- The Sleep Disorders Center of Georgia, Peachtree Dunwoody Medical Center, 5505 Peachtree Dunwoody Road, Suite 548 - Atlanta
- Sleep Disorders Center of Georgia - Gainesville - Gainesville
Ohio
- Community Research - Cincinnati
- Tri-State Sleep Disorders Center, 1275 East Kemper Road - Cincinnati
Kansas
- Vince and Assocaites Clinical Research - Overland Park
Kentucky
- Community Research - Crestview Hills
Mississippi
- Center for Sleep Medicine, 101 Courtney Circle - Hattiesburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 135 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-07 |
| Phase | Phase 2 |
What the finished NCT00401284 record still lists
NCT00401284 is an interventional study that assigns participants to a tested intervention. The registered 135 participants enrollment target is mid-sized for trials with a published cap, below the 283-participant average among 19 other Sleep Initiation and Maintenance Disorders trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Sleep Initiation and Maintenance Disorders appearing as the primary indexed condition, and to 1 intervention - of which EVT 201 is the first listed.
NCT00401284 names 20 study sites across 13 states, led by Florida, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT00401284 about?
NCT00401284 is a clinical study titled "Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness". The purpose of this study is to determine whether a compound known as EVT 201 is effective in treating elderly patients diagnosed with primary insomnia who also have moderate daytime sleepiness.
What is the current status of trial NCT00401284?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 135 participants. The study started on 2006-11. Estimated completion is 2007-07.
What conditions does trial NCT00401284 study?
This clinical trial studies the following conditions: Sleep Initiation and Maintenance Disorders.
What interventions are being tested in trial NCT00401284?
The interventions under investigation include: EVT 201 (DRUG).
Who is sponsoring clinical trial NCT00401284?
This trial is sponsored by Evotec Neurosciences, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00401284 being conducted?
This trial has 20 study locations across Arizona, California, Florida, Georgia, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sleep Initiation and Maintenance Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00401284's enrollment target sits among peer trials
135 11th of 19 higher than 9 of 19 other Sleep Initiation and Maintenance Disorders trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sleep Initiation and Maintenance Disorders trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sleep Healthy Using the Internet Mitigating Insomnia to Address Neurocognitive Difficulties (SHUTi MIND)
RECRUITING · Phase 2
-
Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia
COMPLETED · Phase 2
-
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
COMPLETED · Phase 2
-
Efficacy Study of LY2422347 to Treat Insomnia
COMPLETED · Phase 2
-
Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia.
COMPLETED · Phase 2
-
Mindfulness Meditation for Insomnia
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00870129 · 135 participants · NA
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
- NCT03666000 · 135 participants · Phase 1
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
- NCT04891510 · 135 participants · NA
A Comparative Analysis of REVOLVE, LipoGrafter, and Viality in Autologous Fat Grafting During Breast Surgery
- NCT05121051 · 135 participants · Phase 2
Testing the Effect of the Broccoli Seed and Sprout Extract, Avmacol ES, on the Cancer Causing Substances of Tobacco in Heavy Smokers
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia